UK-based Alchemab Therapeutics, a biopharma seeking to identify and develop naturally occurring therapeutic antibodies from ...

UK headquartered Verdiva Bio Limited today announced its launch as a clinical-stage biopharmaceutical company focused on ...

Italy-based Newron Pharmaceuticals (SIX: NWRN, XETRA: NP5), a biopharma developing therapies for diseases of the central and ...

Cambridge, USA-based biotech Sunbird Bio, which is developing proprietary blood-based technologies to improve diagnosis and ...

AstraZeneca's Lynparza receives NICE approval for treating advanced breast cancer in England and Wales, backed by OlympiAD ...

MaaT Pharma reports positive Phase III results for MaaT013, its microbiome-based therapy for gastrointestinal GvHD, achieving ...

German family-owned pain focused drugmaker Grünenthal announced today that Prof Dr Uli Brödl will assume the role of chief ...

AiCuris appoints Jacques Dumas as CSO to lead research efforts as the company refocuses on infectious disease therapies for ...

Angelini Ventures co-leads a $21 million series A round for Neumirna Therapeutics, supporting its RNA-based therapies for ...

Canadian biotech Aspect Biosystems, which is developing bioprinted tissue therapeutics as a new category in regenerative ...

Insilico Medicine raises over $100 million in series E funding to advance AI-driven drug discovery, including ISM001-055, the ...

Calico Life Sciences, a biotech founded by Alphabet and Arthur Levinson focused on the biology of aging and age-related ...